Form 8-K - Current report:
SEC Accession No. 0000903423-05-000521
Filing Date
2005-07-15
Accepted
2005-07-15 16:55:26
Documents
4
Period of Report
2005-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 corixa8k_07-15.htm 8-K 29126
2 corixa8kex4-1_0715.htm EX-4.1 18156
3 corixa8kex99-1_0715.htm EX-99.1 5123
4 emptybox.gif GRAPHIC 861
  Complete submission text file 0000903423-05-000521.txt   55746
Mailing Address 1900 9TH AVENUE SUITE 1100 SEATTLE WA 98101
Business Address 1900 9TH AVENUE SUITE 1100 SEATTLE WA 98101 2063663700
CORIXA CORP (Filer) CIK: 0001042561 (see all company filings)

EIN.: 911654387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22891 | Film No.: 05957761
SIC: 2836 Biological Products, (No Diagnostic Substances)